ArticleArchives of virology2026
Epigallocatechin gallate inhibits rabies virus glycoprotein‑mediated infection in vitro.
Article in Archives of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Rabies is one of the most lethal zoonotic disease and causes approximately 60,000 human deaths annually. The high cost of immunoglobulin prophylaxis and the need for cold chain maintenance highlight the need for accessible antiviral strategies, particularly in resource-limited settings. Epigallocatechin gallate (EGCG), the major polyphenolic compound of Camellia sinensis, has broad-spectrum antiviral activity. We therefore investigated its activity against Rabies virus (RABV). Because RABV requires BSL-3 containment, we first used a recombinant Vesicular Stomatitis Virus pseudotyped with RABV glycoprotein (pRABV) as a surrogate. EGCG inhibited pRABV infection in a concentration-dependent manner, with an EC
Indexed as
Identifiers
42909665What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.